Stay updated with breaking news from Jeff Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DURHAM, NC / ACCESSWIRE / January 20, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune
DURHAM, NC / ACCESSWIRE / January 19, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune
by Frank Vinluan, NCBiotech writer — December 21, 2020 . RESEARCH TRIANGLE PARK – Heat Biologics, a clinical-stage immunotherapies developer, is moving closer to human testing of a vaccine for COVID-19. The Morrisville-based biotech reported preclinical data showing that its vaccine candidate, ZVX-60, prompted the expression of two proteins key to an immune response. The Heat vaccine also led to the expression of the “spike protein” characteristic of the novel coronavirus. Heat develops drugs that activate T-cells and gets them to proliferate, mounting an immune response to disease...
Dec 18, 2020 It is a modern day parable. The story is courtesy of Louis Cassells, former Religion Editor (think of that...a time when news organizations actually had one) of the United Press International (UPI). The late Paul Harvey made this his annual Christmas monologue. I have added to the story and former WFLA Program Director Jeff Wolf enhanced it with sound production to bring the feature a sense of "being there." It is my favorite Christmas story because it beautifully explains the Advent, the Coming of Christ, to a skeptic who has struggled each Christmas season for years. Please...
MORRISVILLE, N.C. (WTVD) -- This week was dominated by nearly non-stop vaccine news as journalists chronicled a crucial week that will go down as one of the most significant in American history. But even though some vaccines have emerged as early candidates, the research isn't stopping. Triangle biotech firm Heat Biologics is focusing its vaccine candidate on one of the populations most vulnerable to COVID-19: the elderly. Though the trial is still in pre-clinical animal studies, founder Jeff Wolf said they hope to begin human trials in 2021. "Our focus is to combine our vaccine with any appr...